Acute Myeloid Leukemia Research Today is a free monthly online journal that collates and summarizes the latest research about Acute Myeloid Leukemia, including details on aml, symptoms, treatment, information.

Volume 3 (2006), Issue 12 (December)

1. Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia.
   Blood, 108(13): 4202-4. [Abstract] [Full-text]
2. Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approaches.
   Blood, 108(13): 4109-17. [Abstract] [Full-text]
3. Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification.
   Blood, 108(13): 4146-55. [Abstract] [Full-text]
4. PU.1 and Junb: suppressing the formation of acute myeloid leukemia stem cells.
   Cancer Cell, 10(6): 456-7. [Abstract] [Full-text]
5. Mitoxantrone-related acute myeloblastic leukaemia in a patient with metastatic hormone-refractory prostate cancer.
   Anticancer Drugs, 18(2): 233-5. [Abstract] [Full-text]
6. HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia.
   Leukemia, 21(1): 129-35. [Abstract] [Full-text]
7. High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group.
   Leukemia, 21(1): 66-71. [Abstract] [Full-text]
8. Translocation (10;17)(p15;q21) is a recurrent anomaly in acute myeloblastic leukemia.
   Cancer Genet Cytogenet, 172(1): 74-6. [Abstract] [Full-text]
9. Nucleotide excision repair phenotype of human acute myeloid leukemia cell lines at various stages of differentiation.
   Mutat Res, 614(1): 3-15. [Abstract] [Full-text]
10. Assessment of bone marrow angiogenesis in patients with acute myeloid leukemia by using contrast-enhanced MR imaging with clinically approved iron oxides: initial experience.
    Radiology, 242(1): 217-24. [Abstract] [Full-text]
11. Phase I/II study of continuous-infusion troxacitabine in refractory acute myeloid leukemia.
    J Clin Oncol, 25(1): 10-5. [Abstract] [Full-text]
12. Cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients age 60 years or older with previously untreated acute myeloid leukemia.
    J Clin Oncol, 25(1): 25-31. [Abstract] [Full-text]

© 2004-2008 Acute Myeloid Leukemia Research Today. All Rights Reserved.